[go: up one dir, main page]

SI2068909T1 - Modified fgf-21 polypeptides and their uses - Google Patents

Modified fgf-21 polypeptides and their uses

Info

Publication number
SI2068909T1
SI2068909T1 SI200830701T SI200830701T SI2068909T1 SI 2068909 T1 SI2068909 T1 SI 2068909T1 SI 200830701 T SI200830701 T SI 200830701T SI 200830701 T SI200830701 T SI 200830701T SI 2068909 T1 SI2068909 T1 SI 2068909T1
Authority
SI
Slovenia
Prior art keywords
polypeptides
modified fgf
fgf
modified
Prior art date
Application number
SI200830701T
Other languages
Slovenian (sl)
Inventor
Thomas P Cujec
Roberto Mariani
Putnam Anna-Maria A Hays
William M Keefe
Nick Knudsen
Lillian Ho
Jason Pinkstaff
Vadim Kraynov
Original Assignee
Ambrx Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ambrx Inc filed Critical Ambrx Inc
Priority claimed from PCT/US2008/057563 external-priority patent/WO2008121563A2/en
Publication of SI2068909T1 publication Critical patent/SI2068909T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factor [FGF]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI200830701T 2007-03-30 2008-03-19 Modified fgf-21 polypeptides and their uses SI2068909T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US92129707P 2007-03-30 2007-03-30
US98806007P 2007-11-14 2007-11-14
PCT/US2008/057563 WO2008121563A2 (en) 2007-03-30 2008-03-19 Modified fgf-21 polypeptides and their uses
EP08732507A EP2068909B1 (en) 2007-03-30 2008-03-19 Modified fgf-21 polypeptides and their uses

Publications (1)

Publication Number Publication Date
SI2068909T1 true SI2068909T1 (en) 2012-09-28

Family

ID=41790591

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200830701T SI2068909T1 (en) 2007-03-30 2008-03-19 Modified fgf-21 polypeptides and their uses

Country Status (2)

Country Link
CN (1) CN101663046B (en)
SI (1) SI2068909T1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9655974B2 (en) * 2010-07-20 2017-05-23 Novo Nordisk A/S N-terminal modified FGF21 compounds
CN102464712A (en) * 2010-11-11 2012-05-23 重庆富进生物医药有限公司 Deletion human fibroblast growth factor 21 variant and conjugate thereof
TWI527590B (en) * 2011-06-17 2016-04-01 艾瑞斯貿易公司 Lyophilized formulation of FGF-18
CN102603886B (en) * 2012-02-14 2013-08-07 东北农业大学 Mutant fibroblast growth factor and use thereof in treating endocrine diseases
SG10202100667SA (en) * 2012-12-27 2021-02-25 Ngm Biopharmaceuticals Inc Methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
CN103882015B (en) * 2013-12-17 2015-12-02 吉林省奇健生物技术有限公司 A kind of recombinant bacterial strain of high expression human growth hormone and construction process and application
KR102427527B1 (en) 2014-12-23 2022-08-01 노보 노르디스크 에이/에스 Fgf21 derivatives and uses thereof
WO2020096958A1 (en) * 2018-11-05 2020-05-14 Bristol-Myers Squibb Company Method for purifying pegylated protein
CN111187845B (en) * 2020-02-05 2023-03-31 内蒙古农业大学 Application of FGF21 gene in breeding of wool-producing animals and/or regulating hair length
CN114699509A (en) * 2021-09-23 2022-07-05 中南大学湘雅三医院 Application of FGF21 in mechanism for regulating and controlling apoptosis of diabetic ischemic wound cells
CN115804847B (en) * 2022-07-26 2023-08-15 四川省医学科学院·四川省人民医院 A pH/hydrogen peroxide/MMP9 time-sequential response microsphere, a biological carrier loaded with exosomes and its application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7459540B1 (en) * 1999-09-07 2008-12-02 Amgen Inc. Fibroblast growth factor-like polypeptides
DE60043197D1 (en) * 1999-11-18 2009-12-03 Univ Kyoto
CN1914223B (en) * 2004-02-02 2012-02-29 Ambrx公司 Modified human four-helix bundle polypeptides and uses thereof
JP2007531715A (en) * 2004-03-17 2007-11-08 イーライ リリー アンド カンパニー Glycol-linked FGF-21 compound
HUE026826T2 (en) * 2004-10-29 2016-07-28 Ratiopharm Gmbh Remodeling and glycopegylation of fibroblast growth factor (FGF)

Also Published As

Publication number Publication date
CN101663046B (en) 2017-07-28
CN101663046A (en) 2010-03-03

Similar Documents

Publication Publication Date Title
IL237314A0 (en) Modified insulin polypeptides and their uses
IL218776A0 (en) Modified factor vii polypeptides and uses thereof
SI2068909T1 (en) Modified fgf-21 polypeptides and their uses
IL208718A0 (en) Modified factor ix polypeptides and uses thereof
IL225740A0 (en) Factor vii polypeptides that are modified and uses thereof
WO2008121563A3 (en) Modified fgf-21 polypeptides and their uses
IL201791A0 (en) Modified interferon beta polypeptides and their uses
IL207096A0 (en) Modified leptin polypeptides and their uses
GB0708376D0 (en) Novel polypeptides and uses thereof
IL200605A0 (en) Variant activin receptor polypeptides and uses thereof
GB0702020D0 (en) Peptides and their use
ZA201101166B (en) Modified bovine g-csf polypeptides and their uses
GB0721686D0 (en) Polypeptides
GB0916576D0 (en) Polypeptides and uses thereof
GB0916578D0 (en) Polypeptides and uses thereof
SI2483292T1 (en) Variant lovd polypeptides and their uses
GB0702021D0 (en) Peptides and their use
GB0702022D0 (en) Peptides and their use
GB0621513D0 (en) Novel polypeptides and uses thereof
GB0607798D0 (en) Novel polypeptides and use thereof
SI2032708T1 (en) Recombinant novirhabdoviruses and uses thereof
GB0712302D0 (en) Chrondroitinase polypeptides
GB0800700D0 (en) F9 polypeptides and uses thereof
GB0721211D0 (en) F8 polypeptides and uses thereof
GB0800698D0 (en) F2 polypeptides and usesthereof